Department of Anatomy & Embryology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Anatomy & Embryology, Leiden University Medical Center, Leiden, The Netherlands; Department of Animal Biology, University of Málaga, Málaga, Spain.
Biomaterials. 2015 May;51:138-150. doi: 10.1016/j.biomaterials.2015.01.067. Epub 2015 Feb 18.
Cardiomyocytes from human pluripotent stem cells (hPSC-CM) have many potential applications in disease modelling and drug target discovery but their phenotypic similarity to early fetal stages of cardiac development limits their applicability. In this study we compared contraction stresses of hPSC-CM to 2nd trimester human fetal derived cardiomyocytes (hFetal-CM) by imaging displacement of fluorescent beads by single contracting hPSC-CM, aligned by microcontact-printing on polyacrylamide gels. hPSC-CM showed distinctly lower contraction stress than cardiomyocytes isolated from hFetal-CM. To improve maturation of hPSC-CM in vitro we made use of commercial media optimized for cardiomyocyte maturation, which promoted significantly higher contraction stress in hPSC-compared with hFetal-CM. Accordingly, other features of cardiomyocyte maturation were observed, most strikingly increased upstroke velocities and action potential amplitudes, lower resting membrane potentials, improved sarcomeric organization and alterations in cardiac-specific gene expression. Performing contraction force and electrophysiology measurements on individual cardiomyocytes revealed strong correlations between an increase in contraction force and a rise of the upstroke velocity and action potential amplitude and with a decrease in the resting membrane potential. We showed that under standard differentiation conditions hPSC-CM display lower contractile force than primary hFetal-CM and identified conditions under which a commercially available culture medium could induce molecular, morphological and functional maturation of hPSC-CM in vitro. These results are an important contribution for full implementation of hPSC-CM in cardiac disease modelling and drug discovery.
人多能干细胞(hPSC-CM)来源的心肌细胞在疾病建模和药物靶点发现方面具有许多潜在的应用,但它们与人心脏发育早期胚胎阶段的表型相似,限制了它们的适用性。在这项研究中,我们通过荧光微球的位移成像比较了 hPSC-CM 与第 2 孕期人胎儿来源的心肌细胞(hFetal-CM)的收缩力,hPSC-CM 通过微接触印刷排列在聚丙烯酰胺凝胶上。hPSC-CM 的收缩力明显低于从 hFetal-CM 分离的心肌细胞。为了改善 hPSC-CM 的体外成熟,我们利用了针对心肌细胞成熟优化的商业培养基,与 hFetal-CM 相比,hPSC-CM 的收缩力显著提高。相应地,观察到了心肌细胞成熟的其他特征,最显著的是上升速度和动作电位幅度增加、静息膜电位降低、肌节组织改善以及心脏特异性基因表达改变。对单个心肌细胞进行收缩力和电生理学测量表明,收缩力的增加与上升速度和动作电位幅度的增加以及静息膜电位的降低之间存在很强的相关性。我们表明,在标准分化条件下,hPSC-CM 的收缩力低于原代 hFetal-CM,并确定了一种条件,即在这种条件下,一种商业上可用的培养基可以诱导 hPSC-CM 在体外进行分子、形态和功能成熟。这些结果为 hPSC-CM 在心脏疾病建模和药物发现中的全面应用做出了重要贡献。